RE: A note for the educatedI say let's just put those aggressive, non-civilized bashers on ignore and let's keep the quality of this board without giving them the space/attention they crave.
Facts we, here on this board have known for a while :
- Only regenerative treatment for neuronal damage (TBI, Stroke, MS)
- The market is huge and the need unanswered for
- Uses patient's actual brain stem cells (no ethical debate what so ever and no rejection)
- Tests to date have been VERY encouraging (see SCT's website)
- Waiting for Phase 2b results in a couple of months with statistically significant number of patients (96)
- In discussions with potential partners
At 0,30$, not bad of a positioning at this point in time. Risk/Reward ration well worth while IMHO. I know I am repeating things every regular on this board knows, but just to inform the newcomers. BTW always do your own homework! And welcome to SCT if you are a new investor here.
Good trading all!
Micr1